|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1504 NOK | -3.59% |
|
-7.96% | -45.90% |
BerGenBio ASA reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was NOK 0.354 million compared to NOK 0.389 million a year ago. Net loss was NOK 41.64 million compared to NOK 77.19 million a year ago.
Basic loss per share from continuing operations was NOK 0.02 compared to NOK 0.87 a year ago. Diluted loss per share from continuing operations was NOK 0.02 compared to NOK 0.87 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -45.90% | 53.23M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
BERGENBIO ASA 
